Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toward a better understanding of European lyme neuroborreliosis.

Literature DB >> 23667261

Toward a better understanding of European lyme neuroborreliosis.

Gary P Wormser, John J Halperin.

Abstract

Entities: Disease

Keywords: Lyme borreliosis; Lyme disease; erythema migrans; meningitis; neuroborreliosis

Mesh：

Year: 2013 PMID： 23667261 PMCID： PMC3719890 DOI： 10.1093/cid/cit322

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

× No keyword cloud information.

23 in total

1. Oral doxycycline for neuroborreliosis.

Authors: Gary P Wormser; John J Halperin
Journal: Lancet Neurol Date: 2008-06-21 Impact factor: 44.182

2. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid.

Authors: F Strle; E Ruzić-Sabljić; J Cimperman; S Lotric-Furlan; V Maraspin
Journal: Clin Infect Dis Date: 2006-08-08 Impact factor: 9.079

Review 3. Lyme borreliosis.

Authors: Gerold Stanek; Gary P Wormser; Jeremy Gray; Franc Strle
Journal: Lancet Date: 2011-09-06 Impact factor: 79.321

4. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans.

Authors: G Seinost; D E Dykhuizen; R J Dattwyler; W T Golde; J J Dunn; I N Wang; G P Wormser; M E Schriefer; B J Luft
Journal: Infect Immun Date: 1999-07 Impact factor: 3.441

5. Residual brain infection in relapsing-fever borreliosis.

Authors: Diego Cadavid; Marie Sondey; Edwin Garcia; Catherine L Lawson
Journal: J Infect Dis Date: 2006-04-04 Impact factor: 5.226

6. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.

Authors: Unn Ljøstad; Eirik Skogvoll; Randi Eikeland; Rune Midgard; Tone Skarpaas; Ase Berg; Ase Mygland
Journal: Lancet Neurol Date: 2008-06-21 Impact factor: 44.182

7. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.

Authors: B A Fallon; J G Keilp; K M Corbera; E Petkova; C B Britton; E Dwyer; I Slavov; J Cheng; J Dobkin; D R Nelson; H A Sackeim
Journal: Neurology Date: 2007-10-10 Impact factor: 9.910

8. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis.

Authors: Tjasa Cerar; Katarina Ogrinc; Joze Cimperman; Stanka Lotric-Furlan; Franc Strle; Eva Ruzić-Sabljić
Journal: J Clin Microbiol Date: 2008-08-20 Impact factor: 5.948

9. Suspected early Lyme neuroborreliosis in patients with erythema migrans.

Authors: Katarina Ogrinc; Stanka Lotrič-Furlan; Vera Maraspin; Lara Lusa; Tjaša Cerar; Eva Ružič-Sabljič; Franc Strle
Journal: Clin Infect Dis Date: 2013-05-10 Impact factor: 9.079

10. Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients.

Authors: Dustin Brisson; Nilofer Baxamusa; Ira Schwartz; Gary P Wormser
Journal: PLoS One Date: 2011-08-04 Impact factor: 3.240

4 in total

1. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.

Authors: Jörg Steinmann; Jürgen Held; Katharina Ziegler; Anca Rath; Christoph Schoerner; Renate Meyer; Thomas Bertsch; Frank Erbguth; Christian Bogdan
Journal: J Clin Microbiol Date: 2020-08-24 Impact factor: 5.948